Whereas virotherapy has emerged as a novel and promising approach for neoplastic diseases, appropriate model systems have hampered preclinical evaluation of candidate conditionally replicative adenovirus agents (CRAds) with respect to liver toxicity. This is due to the inability of human viral agents to cross species. We have recently shown the human liver tissue slice model to be a facile means to validate adenoviral replication. On this basis, we sought to determine whether our ex vivo liver tissue slice model could be used to assess CRAd-mediated liver toxicity. We analyzed and compared the toxicity of a conditionally replicative adenovirus (AdD24) to that of a replication incompetent adenovirus (Adnull [E1À]) in mouse and human liver tissue slices. To accomplish this, we examined the hepatic apoptosis expression profile by DNA microarray analyses, and compared these results to extracellular release of aminotransferase enzymes, along with direct evidence of apoptosis by caspase-3 immunhistochemical staining and TUNEL assays. Human and mouse liver tissue slices demonstrated a marked increase in extracellular release of aminotransferase enzymes on infection with AdD24 compared to Adnull. AdD24-mediated liver toxicity was further demonstrated by apoptosis induction, as detected by caspase-3 immunohistochemical staining, TUNEL assay and microarray analysis. In conclusion, concordance of CRAd-mediated apoptosis in both the human and the mouse liver tissue slice models was demonstrated, despite the limited replication ability of CRAds in mouse liver slices. The results of this study, defining the CRAdmediated apoptosis gene expression profiles in human and mouse liver, may lay a foundation for preclinical liver toxicity analysis of CRAd agents.
Introduction
Conditionally replicative adenoviruses (CRAds) have shown significant antitumor efficacy in animal models and are currently being evaluated as oncolytic agents for cancer therapy in a number of clinical trials. 1, 2 Clinical toxicity of adenovirus is primarily hepatic, based on the tropism of the virus to the liver. 3, 4 The adenoviralmediated liver toxicity involves both an acute innate response 5 as well as adenovirus sequestration followed by hepatotoxicity as shown with an increase in serum transaminases and diagnostic histopathology. 6 Thus, the practical realization of successful clinical trials is the development of a tumor-selective adenovirus, which replicates in the tumor but not in normal liver.
While the acute innate response to adenoviral infection in the liver has been characterized, 5, 7 the evaluation of direct hepatotoxicity by adenoviruses in a virotherapeutical context has been limited. This is mainly due to limited available model systems for preclinical evaluation of viral-mediated liver toxicity. For a variety of reasons mice have been employed as the prototypic animal model for preclinical study of virotherapy agents. Ideally, a mouse model should mimic the target human disease in its etiology, genetics, clinical presentation, and progression. 8 However, this approach has been challenging in the field of virotherapy because human adenoviruses can presumably only partially replicate in rodents. 9, 10 Thus, the development of stringent substrate systems to allow the fullest preclinical characterization of CRAd-mediated direct hepatotoxicity is a central task in the field of virotherapy.
To address this issue, we endeavored to explore the utility of precision-cut slices derived from human or murine livers as a tool to characterize ex vivo liver toxicity mediated by CRAds in a preclinical context. Precision-cut tissue slice technology offers a powerful and representative ex vivo model system for preclinical infectivity analysis, as the human liver tissue slices contain all the cell types present in whole liver and maintain their threedimensional structure in vitro. [11] [12] [13] We have recently explored this method to provide a facile means to ascertain the replicative specificity of CRAd agents in a stringent context that parallels human clinical use. Of note, gene expression profiles in liver tissue slices have been shown to be similar to the in vivo gene expression in a variety of study contexts 11 and, thus, represents the most stringent available ex vivo model for human liver. 14 Based on the available studies of adenovirus-mediated hepatotoxicity, 6 we hypothesized that apoptosis of hepatocytes is a major mechanism involved in CRAdmediated liver toxicity. 15, 16 For this reason, we examined the genes involved in Ad-mediated apoptosis in human and liver tissue slices using DNA microarrays. Consistent with this concept, conservation between mouse and human genes in respect to apoptosis programs has been reported. 17 In this study, we analyzed and compared the direct mediated toxicity of a replication competent adenovirus to that of a replication incompetent adenovirus in mouse and human liver tissue slices. We utilized AdD24, which contains a 24-bp deletion in the CR2 of the E1A gene, 18, 19 as a representative CRAd to determine differences in liver toxicity compared to that of a nonreplicative adenovirus Adnull, which is E1-deleted. To accomplish this, we examined the apoptosis expression profile by DNA microarray analyses of adenovirus-infected liver tissue slices, and compared these results to extracellular release of aminotransferase enzymes, along with direct evidence of apoptosis by caspase-3 immunhistochemical staining and TUNEL assays. The results of this study, defining the similarities and differences in adenoviral induced apoptosis in our ex vivo model using human and mouse liver slices may lay a foundation for preclinical liver toxicity analysis of CRAd agents.
Materials and methods
Human primary liver tissue samples Approval was obtained from the Institutional Review Board for all studies on human tissue. Human liver samples were obtained (Department of Surgery, University of Alabama at Birmingham (UAB)) from eight adenovirus seronegative donor livers prior to transplantation into recipients. All liver samples were flushed with University of Wisconsin (UW) solution (ViaSpan, Barr Laboratories, Inc. Pomona, NY) before harvesting and kept on ice in UW solution until slicing. Time from harvest to slicing was kept at an absolute minimum (o2 h).
Mouse primary liver tissue samples Ten C57BL/6 mice ranging in age from 6 to 10.5 weeks were used for this study after receipt of approval from the Institutional IACUC. Animals were killed by CO 2 asphyxiation, and liver samples were obtained. Time from harvest to slicing was kept at an absolute minimum (o2 h).
Slice preparation with the krumdieck tissue slicer The Krumdieck tissue slicing system (Alabama Research & Development) was used in accordance with the manufacturer's instructions and previously published techniques.
12,20 An 8 mm coring device (Alabama Research and Development, Birmingham) was used to retrieve an 8 mm diameter core of tissue from the liver (human and mouse). This was then placed in a slicer filled with ice-cold culture media. Slice thickness was set at 250 mm using a tissue slice thickness gauge (Alabama Research and development) and slices were cut using a reciprocating blade at 30 r.p.m. Afterwards, these slices were stored in ice-cold culture media, which served as a wash/equlibration solution between preservation in UW solution and culture media.
Tissue slice culture Tissue slices were placed into six-well plates (1 slice/well) containing 2 ml of complete culture media (William's Medium E with 1% antibiotics, 1% L-glutamine, and 10% FBS). The plates were then incubated at 371C/5% CO 2 in a humidified environment for up to 48 h. A plate rocker set at 60 r.p.m. was used to agitate the slices and ensure adaequate oxygenation and viability. 13 
Viral infection
Adnull, an E1 deleted adenovirus, was chosen as a control nonreplicating virus. The CRAd AdD24 has been described previously (ref) , and was constructed by homologous recombination in 'E1-complementing 293' cells between the pXC1 (Microbix Biosystems, Toronto, Canada) derivative PXC1-D24, carrying a 24-bp deletion in the pRb-binding CR2 domain of E1A, 18 and pBHG11. All viruses used in this study have no reporter gene. All viral infections were performed with 500 viral particles/ cell in complete culture media containing 2% FBS. Cell number for tissue slices was estimated at 1 Â 10 6 cells per slice based on a 10-cell thick slice (B250 mm) and 8-mm slice diameter. Infections were allowed to proceed for the intended time, subsequently media was removed and replaced with complete culture media containing 10% FBS. Slices were removed from culture at 4, 10, 26 or 28 and 43 h postinfection.
RNA preparation
Tissue slices, both infected and noninfected (as a control), were placed in RLT buffer (RNEasy RNA extraction kit, Qiagen, Valencia, CA) with b-mercaptoethanol (Sigma, St Louis, MO). Slices were homogenized immediately with an ultrasonic sonicator (Fisher Scientific Model 100) at a setting of 15 W for 10 s. After centrifuging the homogenate, the supernatant was transferred to separate Eppendorf tubes for subsequent RNA purification with the Qiagen RNEasy kit, according to the manufacturer's directions. Purified RNA samples were eluted with 30 ml of DNAse/RNAse free water and stored at À801C until analysis.
Assay of adenovirus copy number Quantitative real-time RT-PCR was performed for the E4 region of adenovirus as previously described, 14, 21 using the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) human housekeeping gene expression as an internal control. Results are presented as E4 copies/ng of total RNA.
Direct liver toxicity analysis of Adnull and AdD24 by determination of liver enzymes levels The levels of alanine transaminase (ALT), lactate dehydrogenase (LDH), and aspartate aminotransferase (AST) were determined in the culture media by the SFBC protocol. 13 We quantitated ALT, LDH, and AST levels at 4, 10, 28, and 43 h postinfection in human liver tissue slices from eight different patients (University of Alabama Hospital Laboratories, University of Alabama at Birmingham, AL) and 10 mice (ANIMALLABS, Diagnostic testing, George Carden, Birmingham, AL).
Microarray hybridization
For gene expression analysis, the commercially available Affymetrix Human Genome U133 Plus 2.0. Array and Mouse Genome 430 2.0 Array were used. The Human Genome U133 Plus 2.0 array contains over 47 000 transcipts including 38 500 well-known genes. The Mouse Genome 430 2.0 contains 39 000 transcripts including 34 000 well-characterized genes. A total of six expression arrays were analyzed, three Human Genome U133 Plus 2.0 arrays for human liver tissue slices (noninfected, Adnull-and AdD24-infected liver tissue-slices) and three Mouse Genome 430 2.0 arrays for mouse liver tissue slices (noninfected, Adnull-and AdD24-infected liver tissue slices). Detailed procedures for RNA labeling and array process are presented in the Manufacturer's Gene Chip Expression Technical Manual (Affymetrix). Briefly, total RNA in the amount of 2 mg of each sample was used for double-stranded cDNA generation by linear amplification using oligo dT-T7 primer and reverse transcriptase. Subsequently, biotin-labeled cRNA were synthesized by in vitro transcription (IVT) using the 3 0 -Amplification Reagents for IVT labeling (Affymetrix). The quality of total RNA and the quality of biotin-labeled cRNA were determined using the RNA Nano chip on Agilent BioAnalyzer. Prior to hybridizing to the expression arrays, the quality of the hybridization target was determined by hybridization to a Test 3 array that indicated the efficacy of the RT/IVT reaction by the ratios of expression level of 5 0 -3 0 of house-keeping genes (b-actin and GAPDH). The arrays were hybridized overnight at 451C for 16 h in a GeneArray Hybridization Oven 640 (Affymetrix). The next day, the arrays were washed and stained in the Fluidics Station 450 (Affymetrix) and scanned by the High Resolution GeneChip Scanner 3000 (Affymetrix). Gene expression levels were extracted using GeneChip Operating Software (GCOS 1.1, Affymetrix) and paired comparison between the gene expression levels in the Ad treatment groups and that in the untreated group were performed to determine the fold change for each transcript. The expression level and/or fold change were then subjected to data query and data mining in Data Mining Tool (DMT).
Microarray data analysis and annotation
We generated a list of genes involved in apoptosis (proor antiapoptotic), which were derived from an annotation file downloaded from the Affymetrix website (www.affymetrix. com). The list currently contains 725 probe sets equivalent to 314 genes. The microarrayderived probe set intensities were first filtered by fold changes and then by functions such as those pertaining to apoptosis. Given the exploratory nature of the microarray used in this study, the filtered list was later selectively verified by other methods such as RT-PCR.
To compare human vs mouse gene expression, the same genes (or probe set identifiers, IDs) from both human and mouse were matched based on an ortholog file downloaded from the Affymetrix web site. The file contains all probe sets IDs of human U133 plus chip and their matching mouse 430-2 chip probe set IDs. The file was used to generate lists of genes involved in apoptosis that contained genes common to both human and mouse liver tissue slices (155 genes) or genes unique to either human liver tissue slices (150 genes) or mouse liver tissue slices (90 genes).
Quantitative real-time reverse transcriptase PCR To further validate the microarray results, quantitative real-time RT-PCR was performed. Fluorescent TaqMan probes and the primer pairs used for real-time RT-PCR were designed using Primer Express 1.0 (Perkin-Elmer, Foster City, CA) and synthesized by Applied Biosystems (Foster City, CA). Nine messenger RNAs (mRNAs) were analyzed, including EGLN3, BNIP3L, TIA1, CD38, GADD45B, BAX, BCL10, CASP3 and CASP4. GAPDH was used as an internal control. cDNA was prepared from total RNA samples using a first strand synthesis kit (Invitrogen), according to the manufacturer's protocol. For real-time RT-PCR assay, each 9 ml PCR reaction contained 3 mM MgCl 2 , 300 mM each dATP, dCTP, and dGTP, 600 mM dUTP, 100 nM of forward, reverse primers, and probe, 1 U of rTth DNA polymerase, 0.025% BSA, and RNase-free water. Plasmid standard or 1 ml of RNA sample was added into each assay tube. Negative controls with no template were performed for each reaction series. Real-time PCR reaction was carried out using a LightCyclert System (Roche Molecular Biochemicals, Indianapolis, IN). Thermal cycling conditions were subjected to 30 min at 481C, 10 min at 951C, then 40 cycles of 15 s at 951C, and 1 min at 601C. Data were analyzed with LightCycler software.
Assessment of apoptosis by TUNEL assay
Apoptosis was assessed by detection of DNA fragmentation using an in situ TUNEL assay and examined by light microscopy.
Caspase-3 staining Formalin-fixed, paraffin-embedded human and mouse liver tissue slices were stained with a rabbit polyclonal antibody specific for caspase-3 (Cleaved Caspase-3 Ab, Cell Signaling Technology, # 9661). Biotinylated goat anti-rabbit antibody was added as the secondary bridging antibody to HRP-conjugated streptavidin. Staining was visualized with a DAB/NiCl 2 chromogen. As a negative control, staining was performed without the primary antibody.
Statistical analysis for RT-PCR
Experiments were performed with liver tissue slices from eight human donors and 10 mouse donors in triplicates. Real-time PCR results were compared using Student's t-test assuming nonequal variance and independence.
Results
Demonstration of productive adenoviral replication in mouse and human liver tissue slice models Although previous studies have shown poor human adenoviral replication in vivo in rodents, 9, 10 we compared the extent of adenoviral replication in our ex vivo model using human and mouse liver tissue slices (Figure 1 ). For this, mouse and human liver tissue slices were infected with nonreplicating Adnull [E1À] or replicating AdD24 [E1 þ ] at 500 viral particles/cell, a titer consistent with maximum infectivity (data not shown). Following infection, E4 copy number (a surrogate for adenoviral genome copy number) was analyzed at 12 and 28 h by quantitative real-time RT-PCR. 14 In human liver tissue slices, AdD24 showed evidence of replication between 12 and 28 h after infection, by an increase in E4 copy number from 7507100 to 21007500 (a 2.970.7-fold increase) (Figure 1a) . Mouse liver tissue slices showed a more modest AdD24 replication between 12 and 28 h, with the E4 copy number increasing from 13075 to 175710 (a 1.3670.07-fold increase) (Figure 1b) . The Adnull E4 copy number remained at low levels in both human and mouse liver slices, consistent with its nonreplicative phenotype (data not shown).
Comparison of Adnull and AdD24 mediated direct hepatotoxicity by determination of extracellular release of liver enzymes We next examined the correlation between AdD24 replication and toxicity in mouse and human liver tissue slices. To accomplish this, we compared the toxicity of Adnull and AdD24 in the human and mouse liver tissue slice models by measuring the release of aminotransferase enzymes in the extracellular matrix milieu, 13 which is widely used as a surrogate marker for liver damage. As a sensitive marker of hepatocellular injury, we quantitated ALT, LDH and AST levels at 4, 10, 28, and 43 h postinfection in the culture medium of liver tissue slices from eight human liver samples ( Figure 2 ) and from 10 mouse liver samples (Figure 3) . Based on the relatively poor replication of AdD24 in mouse liver tissue slices compared to human liver tissue slices demonstrated above, we hypothesized that little or no liver toxicity would be displayed. Surprisingly, in both human and mouse liver tissue slices, infection with AdD24 resulted in a statistically significant higher ALT, LDH and AST release (Po0.05) than infection with Adnull between 28 and 43 h post-infection (Figures 2 and 3 ). These results demonstrate that both mouse and human liver tissue slices infected with AdD24 had increased hepatotoxicity compared to noninfected tissue slices or tissue slices infected with the nonreplicative Adnull. However, a correlation between AdD24 replication and toxicity in mouse liver tissue slices was not observed.
Apoptosis as an indicator of direct adenoviral mediated hepatotoxicity Next, we investigated whether apoptosis could be used as an indicator of CRAd-mediated direct liver toxicity. We evaluated this hypothesis by determining levels of caspase-3 activity assessed by immunohistochemical staining of human liver tissue slices (Figure 4) . Antibodies directed against an epitope on caspase-3 were immunohistochemically nonreactive in the control human liver tissue slice (Figure 4a ) as well as in the Adnull infected human liver tissue slices after 28 h of infection (Figure 4b ). However, an immunoreactive (positive) cytoplasmic and nuclear caspase-3 staining was observed in the AdD24 infected human liver tissue slices (Figure 4c ). These results show that apoptosis was undetectable by caspase-3 immunohistochemical staining in human liver slices infected by nonreplicating Adnull. Importantly, apoptosis was detected in human liver slices infected by the replicating AdD24. These results suggest that apoptosis may be used as a surrogate marker for demonstration of AdD24 mediated liver toxicity in the human liver tissue slice model.
Determination of Adnull and AdD24 direct mediated hepatotoxicity by TUNEL assay Next, we investigated whether we could correlate AdD24-mediated hepatotoxicity in human liver tissue slices compared to mouse liver tissue slices by detection of DNA fragmentation using TUNEL assays at 28 h after adenoviral infection ( Figure 5 ). In both the mouse and the human liver tissue slices, no TUNEL positive cells were detected either in the noninfected control or in the Adnull infected liver tissue slices (Figure 5a and b) . In contrast, positive nuclei (brown nuclei with nuclear condensation) were observed in hepatocytes from the mouse and human liver tissue slices infected with AdD24 (Figure 5c ). These data that AdD24 induced apoptosis is detected by TUMEL assay in the human liver slice model, are consistent with the results of caspase 3 immunohistochemical staining shown in Figure 4 . Importantly, AdD24 induced apoptosis was detected by TUNEL assay not only in the human but also in the mouse liver tissue slices model.
Comparison between
AdD24 and compared to their noninfected counterparts. In this experiment, the microarray data served as an indicator of changes in expression of apoptosis genes in mouse and liver tissue slices after Ad infection. Expression was detected in 155 overlapping genes involved in apoptosis that were common to both the human and the mouse liver tissue slices; apoptosis genes showing a twofold or greater change were considered to be significantly modulated. Of these, 15 (9.7%) were classified as upregulated after infection with AdD24 or Adnull, compared to noninfected liver tissue slices (Table 1 ). In addition, 7 (4.5%) of these were classified as downregulated (Table 2) . Expression was also detected in 150 apoptosis genes that were unique to the human liver tissue slices. Of these, 19 (12.6%) were changed after infection with AdD24 or Adnull, compared to noninfected human liver tissue slices Table 3 ). Finally, expression was detected in 90 apoptosis genes that were unique to the mouse liver tissue slices Of these, 15 (12.6%) were changed after infection with AdD24 or Adnull, compared to noninfected mouse liver tissue slices (Table 4) .
To quantitatively evaluate and confirm the descriptive analysis of our microarray assay, we selected nine different representative apoptosis genes (Table 1 , indicated in bold) common between human and mouse, which showed more than two-fold increase after infection with either Adnull or AdD24. The expression levels of these nine genes were analyzed by quantitative real-time RT-PCR in matched Adnull and AdD24 infected liver tissue slices from human donors and mice. First, samples derived from Adnull infected human liver tissue slices were compared to samples derived from AdD24 infected human liver tissue slices (n ¼ 8). Next, samples derived from Adnull infected mouse liver tissue slices were compared to samples derived from AdD24 infected mouse liver tissue slices (n ¼ 10). Table 5 represents the results of the quantitative PCR analysis for these selected apoptosis genes, listing the number of individual human or mouse liver donors showing a significant upregulation of apoptosis genes after infection with AdD24 compared to Adnull for each gene. Next, we compared the average expression of apoptosis genes among all Adnull infected human liver tissue slices compared to all AdD24 infected human liver tissue slices for each donor. The same analysis was performed for the Adnull and AdD24 infected mouse liver tissue slices for each donor. In this regard, the analysis of quantitative real-time PCR results showed a significantly (Po0.05) different expression in eight out of nine selected apoptosis genes (Table 5 , symbol indicated in bold). For each of these eight apoptosis genes, at least 30% of the human liver donors and 70% of the mouse liver donors were shown to have a significantly higher upregulation by AdD24 when compared to Adnull. These results thus confirm the increased apoptosis induction by AdD24 infection compared to Adnull in both tissue slice models, as observed in the other toxicity assays performed in this study.
Discussion
Useful models to evaluate potential liver toxicity of adenoviral gene therapies, particularly adenoviral virotherapy, are urgently required. Whereas virotherapy has emerged as a novel and promising approach for neoplastic diseases such as ovarian cancer, the limited repertoire of appropriate model systems has hampered clinical translation of candidate conditionally replicative adenovirus agents (CRAds). To address this issue, we have explored the method to derive tissue explants from human and normal tissues via a tissue slice technique using the Krumdieck tissue slicer. 14 We showed the fidelity of adenovirus replication between known in vitro cell lines and their related tissue slice explants.
14 Finally, and most importantly, we established the utility of tissue slices for monitoring adenovirus replication in primary human tumors as well as replication selectivity using human liver.
14 On this basis, we have extended our studies herein to investigate whether our novel human liver tissue slice model could provide a mean to more fully characterize CRAd-mediated liver toxicity.
First, we investigated whether the observed liver toxicity in the human liver tissue slice model was related to the replicative phenotype of the conditionally replicative adenovirus AdD24, currently in phase I trials. 22 In this regard, AdD24 contains a 24-bp deletion in the CR2 of the E1A gene, 18, 19 and serves as a representative CRAd to determine differences in liver toxicity compared to a representative nonreplicating adenovirus (Adnull). Since human serotype adenoviruses developed as CRAds undergo only limited replication in a murine host background, 10 we sought to validate this notion by comparing AdD24 replication in human and mouse liver tissue slices. Human adenovirus undergoes abortive infection in murine target cells characterized by high early gene expression with early to late transition blocks. 9 Based on this consideration, the low E4 copy number in murine liver and the three-fold higher copy number in human liver was not unexpected.
Next, we sought to compare the AdD24 and Adnull induced toxicity between the human and the mouse liver tissue slice model. In this regard, extracellular release of the aminotransferases ALT, LDH and AST were significantly higher after infection with AdD24 than Adnull in both human and mouse liver tissue slices. These findings question the original hypothesis relating viral replication in the S-phase of the cell cycle to Figure 5 AdD24 induces apoptosis in the mouse and the human liver tissue slice model at the 28-h time point as detected by a TUNEL assay. As seen by conventional light microscopy, the control (a) and Adnull infected (b) mouse and human liver tissue slices showed no immunoreactivity, whereas AdD24 infection in the mouse and human liver tissue slices (c) led to TUNEL-immunoreactivity in the hepatocytes ( brown nuclear staining). Only genes with X2-fold change were considered to be modulated. NC ¼ no change.
toxicity. 23 The observed AdD24 mediated hepatotoxicity in the mouse liver tissue slices suggests that the effects of various E1A-mutants on S-phase induction, viral replication, and cytotoxicity may not be directly related. The mechanisms of reduced cytotoxicity of AdD24 in normal cells thus remain unclear. 23 In addition, we sought to compare AdD24 and Adnull mediated liver toxicity in human liver by using apoptosis as an indicator. Previous studies of apoptosis in viral hepatitis applied a variety of different methods, including activation of caspase-3 [24] [25] [26] and TUNEL assays 27,28 as surrogate markers. Our results demonstrate that positive caspase-3 immunoreactivity was indeed observed in human liver tissue slices infected with AdD24, but not Adnull. In addition, both human and mouse liver tissue slices showed positive TUNEL staining when infected with AdD24 but not with Adnull. Importantly, these data agree with the higher extracellular release of Only genes with X2-fold change were considered to be modulated. NC ¼ no change. Only genes with X2-fold change were considered to be modulated.
aminotransferase enzymes in liver slices infected with AdD24 compared to Adnull. Finally, we investigated the effects of Adnull and AdD24 infection on apoptosis gene expression via microarray analysis. We identified 15 apoptosis genes common to both human and mouse liver tissue slices that were upregulated and seven apoptosis genes that were downregulated after Ad infection of liver slices. Nine of these upregulated apoptosis genes were selected for verification by real-time RT-PCR. Of note, the evaluation of apoptosis gene expression occurred at 28 h after adenoviral infection, based on our previous data, which indicated that this time point was optimal for evaluation and viability of Ad infected tissue slices. 14 The apoptosis genes chosen included EGLN3, BNIPL3L, TIA-1, CD38 (p45), GADD45b, BAX, BCL10, CASP3 and CASP4.
Our RT-PCR data verified a statistically significant upregulation of caspase-3 in the AdD24 infected human Only genes with X2-fold change were considered as modulated. The number of donors and mice showing a significant upregulation of the selected apoptosis genes in liver tissue slices after infection with AdD24 compared to Adnull are indicated. All data points are triplicates of slices.
and mouse liver tissue slices, as also observed in our immunohistochemical analysis. Of the 11 capsases identified to date, caspase-3 is considered a central player mediating apoptosis, correlating this result with the observed TUNEL staining in AdD24 infected liver slices. Other regulators of apoptosis include the Bcl-2 family. 29, 30 In this regard, the observed upregulation of both Bax and BNIPL-3 in human and mouse liver tissue slices after AdD24 infection also corresponds to the observed increase in apoptosis.
In addition to proteins of the Bcl-2 family, EGLN3, a homologue of the Caenorhabditis elegans gene egl-9 31 was increased by AdD24 in human and mouse liver tissue slices. EGLN3 has been implicated in the regulation of growth, differentiation and apoptosis in muscle and nerve cells. Furthermore, the proapoptotic proteins Bcl10, TIA-1 32 and GADD45b 33 were strongly induced in AdD24 infected human and mouse liver tissue slices, corroborating the induction of apoptosis on AdD24 infection.
In our study AdD24, which contains a 24-bp deletion in the CR2 of the E1A gene, 18, 19 served as a representative CRAd to determine differences in liver toxicity compared to Adnull. In this regard, the effects of E1A on cellular biology are extremely complex and poorly understood. The adenoviral E1A gene product plays a critical role in altering the biology of resting normal cells to facilitate viral replication. Modification of the adenoviral E1A gene is an attractive way to restrict viral replication to proliferating cells. 23 Wild-type E1A binds to Rb, thereby releasing E2F and inducing S phase, a process that is thought to be important for viral replication in resting cells. AdD24 containing a deletion of the Rb-binding site within E1A has been hypothesized to be defective in inducing S phase and therefore replication-impaired in normal cells, while retaining full replication capacity in cells with defective Rb function. 18, 19 The Rb pathway is inactive in almost all human tumors, including ovarian cancer. 18, 19 However, our results indicate that a deletion of the Rb-binding site in E1A alone does not prevent hepatotoxicity. In this context, it has been shown that deletion of the Rbbinding site in E1A alone has only a small effect on the ability of the virus to induce S phase. 23 AdD24 can replicate to wild-type levels in growth arrested HUVEC 23 and in an organotypic model of human stratified epithelium. 34 In this regard, it has been shown that in addition to deletion of the Rb-binding domain, a deletion within the N-terminus of E1A is required to substantially reduce the ability of the virus to induce S-phase. 23, 35, 36 It remains unclear which of several E1A modifications that disturb the interaction with various cellular proteins would be most effective at protecting normal cells, while preserving the oncolytic potency of the virus.
Although in this study liver toxicity and apoptosis induction has been demonstrated using our liver tissue slice model, it is important to note that the immune response to adenoviruses is obviously not applicable herein. In this regard, using immune competent animals, most of the administered adenovirus is sequestered and cleared by Kupffer cells. 37 Fulminant hepatotoxicities caused by adenoviruses have been observed in severe immune suppressed patients. 38 Of note, the cotton rat model has been proposed as an animal model to evaluate oncolytic Ad vectors, 39 due to the semipermissive nature of the cotton rat for human Ad replication. Adenovirus biodistribution and replication, as well as any associated organ toxicities have been assessed using E1A-deficient vectors in the cotton rat. 40 To date, the cotton rat model has also been a particularly useful animal model of adenovirus pneumonia. 41, 42 While the tissue slice model does not consider the immune response, demonstration of reduced liver toxicity will likely be predictive of an increased therapeutic index. However, to validate this hypothesis, a direct comparison between the determination of adenoviral vector mediated toxicity using tissue slice model and the determination of in vivo toxicity on adenovirus administration in the cotton rat model would likely be useful.
In conclusion, useful models for evaluation of in vivo liver toxicity of new generation gene therapy vectors are needed. In this regard, the human liver tissue slice model demonstrates CRAd-mediated hepatotoxicity in primary human liver samples with maintained liver structure and composition. Furthermore, a concordance of CRAd mediated liver toxicity in both the human and the mouse liver tissue slice models was demonstrated, despite the reported limited replication ability of CRAds in mice. Thus, our data implicate that the mouse liver tissue slice model may be in fact better than expected in predicting liver toxicity to CRAds. The data presented here thus suggest both liver tissue slice models, human and mouse, to be a valid powerful tool for ex vivo preclinical evaluation for virotherapy liver toxicity, to aid in the clinical translation of CRAds.
